Development prospects of the veterinary drug industry

Veterinary drug industry sales continue to rise

In recent years, my country's veterinary drug industry has made great progress, and veterinary drug sales continue to rise. From 2016 to 2021, the sales scale of domestic veterinary drug products increased from 47.229 billion yuan to 68.618 billion yuan, with an average annual compound growth rate of approximately 8%. Sales are expected to exceed 77 billion yuan in 2022.

The number of new veterinary drug registrations is basically the same

In terms of innovation, my country's veterinary drug industry started late, with low investment, insufficient accumulation and precipitation of technology, and weak R&D strength, which affects the sustainability of the veterinary drug industry. healthy development. Since 2016, the number of new veterinary drugs approved in my country has remained at around 70 each year. In 2022, 78 new veterinary drugs will be approved, a record high, but there has yet to be a historic breakthrough in quantity.

The innovation dilemma of veterinary drug companies

At present, the innovation potential of my country’s veterinary drug companies needs to be continuously explored. In addition to accelerating the training of professional talents for colleges and universities and research, companies should abandon the concept of only pursuing quick profits, truly invest technical personnel in R&D, and gradually establish mature and stable R&D teams.

Ranking of scientific and technological innovation content of veterinary drug companies

According to data from the Science Popularization Center of the National Animal Health and Video Safety Innovation Alliance, the Veterinary Drug Lawyuan has compiled a ranking of the total "technological innovation" content of veterinary drug manufacturers. . Generally speaking, my country's veterinary drug industry is relatively developed in the southeastern region and has innovative vitality. The top 100 veterinary drug manufacturers in terms of total scientific and technological innovation content are most distributed in Shandong and Zhejiang provinces, with 17 companies each, followed by Guangdong Province with 10 companies.

At the National Two Sessions in 2023, Zhang Weiyuan, chairman of Huisheng Biotech, said that scientific and technological innovation is the key to promoting the high-quality development of the veterinary drug industry and driving my country from a big country in veterinary drugs to a strong country in veterinary drugs. To this end, he put forward the understanding and needs of front-line practitioners in the industry for the innovative development of the veterinary drug industry, hoping that the government would increase support for scientific and technological innovation in veterinary drugs and promote the high-quality development of the veterinary drug industry. For more detailed research and analysis on this industry, please see the "China Veterinary Drug Industry Development Prospects Forecast and Investment Strategic Planning Analysis Report" by the Qianzhan Industry Research Institute